Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors.
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.
Front Genet. 2013; 4: 66
Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, Shelling AN, Baguley BC
The NRAS and BRAF genes… Continue reading
Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy With Streptomycin and Rifampicin.
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
PLoS Negl Trop Dis. 2013 May; 7(5): e2191
Yeboah-Manu D, Kpeli GS, Ruf MT, Asan-Ampah K, Quenin-Fosu K, Owusu-Mireku E, Paintsil A, Lamptey I,… Continue reading
Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(Ethylsulfinyl)-6-(Trifluoromethyl)pyrimidine (BETP), a Small Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 (GLP-1) Receptor.
Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 (GLP-1) Receptor.
Drug Metab Dispos. 2013 May 7;
Eng H, Sharma R, McDonald TS, Edmonds DJ, Fortin JP, Li X, Stevens… Continue reading
Viability Reagent, PrestoBlue, in Comparison With Other Available Reagents, Utilized in Cytotoxicity and Antimicrobial Assays.
Viability Reagent, PrestoBlue, in Comparison with Other Available Reagents, Utilized in Cytotoxicity and Antimicrobial Assays.
Int J Microbiol. 2013; 2013: 420601
Lall N, Henley-Smith CJ, De Canha MN, Oosthuizen CB, Berrington D
This study compared different commercially available viability… Continue reading
A New Class of Small Molecule Inhibitor of BMP Signaling.
A New Class of Small Molecule Inhibitor of BMP Signaling.
PLoS One. 2013; 8(4): e62721
Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S, Wang Y, Triffitt JT, Cuny GD, Yu PB, Hill CS, Bullock AN… Continue reading